EUVIMEDEUVIMED entdecken
Fallbericht

Hybrid granular cell tumor/perineurioma: a report of two rare cases with PIK3CA mutations

Ani Toklu, Gauri Panse, George Jour, Konstantinos Linos, Jeffrey M Cloutier, Carina A Dehner

Virchows Archiv · 2025

DOI: 10.1007/s00428-025-04089-3 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Virchows Archiv, 2025. Verfasst von Ani Toklu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Indiana University Hospital, Indianapolis, IN, 46202, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Class I Phosphatidylinositol 3-Kinases, Granular Cell Tumor, Mutation. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Memorial Sloan-Kettering Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hybrid peripheral nerve sheath tumors (PNSTs) are rare mesenchymal neoplasms with dual differentiation, most often combining two of the three main PNST types: schwannoma, neurofibroma, and perineurioma. Recognized by the WHO since 2013, these tumors can also exhibit fewer common combinations, such as hybrid granular cell tumor/perineurioma. We herein report two rare cases of hybrid granular cell tumor perineurioma with molecular analysis. Both tumors presented as dermal to subcutaneous, well-circumscribed lesions composed of a combination of spindled and granular cell components. By immunohistochemistry, the granular cells were positive for S100, SOX10, and CD68, while the perineurial cells were highlighted by EMA and GLUT1 stains. Subsequent molecular testing revealed pathogenic mutations involving PIK3CA in both cases. Our study expands on the clinical and pathologic spectrum and provides the first molecular data on these unusual neoplasms. Further, we provide a comprehensive review of the literature of all previously reported cases and briefly discuss relevant differential diagnoses and their molecular features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorClass I Phosphatidylinositol 3-KinasesGranular Cell TumorMutationNeoplasms, Complex and MixedNerve Sheath NeoplasmsHumansDiagnosis, DifferentialImmunohistochemistry

Stichwörter der Autor:innen

Granular cell tumorHybrid peripheral nerve sheath tumorPerineuriomaPeripheral nerve sheath tumorsSchwannoma

Substanzen

Biomarkers, TumorClass I Phosphatidylinositol 3-KinasesPIK3CA protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Indiana University Hospital, Indianapolis, IN, 46202, USA.
  • Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.
  • Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Department of Pathology and Dermatology, New York School of Medicine, New York, NY, USA.
  • Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.

Förderung

  • Memorial Sloan-Kettering Cancer Center

Zitieren

APA

Toklu, A., Panse, G., Jour, G., Linos, K., Cloutier, J. M., & Dehner, C. A. (2025). Hybrid granular cell tumor/perineurioma: a report of two rare cases with PIK3CA mutations. Virchows Archiv. https://doi.org/10.1007/s00428-025-04089-3

Vancouver

Toklu A, Panse G, Jour G, Linos K, Cloutier JM, Dehner CA. Hybrid granular cell tumor/perineurioma: a report of two rare cases with PIK3CA mutations. Virchows Archiv. 2025. doi:10.1007/s00428-025-04089-3

BibTeX
@article{Toklu2025,
  author = {Toklu, Ani and Panse, Gauri and Jour, George and Linos, Konstantinos and Cloutier, Jeffrey M and Dehner, Carina A},
  title = {Hybrid granular cell tumor/perineurioma: a report of two rare cases with PIK3CA mutations},
  journal = {Virchows Archiv},
  year = {2025},
  doi = {10.1007/s00428-025-04089-3}
}
Kostenlos starten →